Diabetic Nephropathy in Type 2 Diabetes with Proteinuria

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2018-04-17
FDA Approved: IRBESARTAN — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal's original application for irbesartan (IRBESARTAN), enabling a generic version of the antihypertensive medication.